Jennifer Herrmann

Jennifer Herrmann

Helmholtz Institute for Pharmaceutical Research Saarland, Saarland University

Affiliated withSaarland UniversityGerman Centre for Infection Research (DZIF)

Research Area

Biography

Jennifer studied chemistry at the Technical University Kaiserslautern and received her diploma in 2007. She worked as visiting scholar at Drug Discovery Ltd. in Glasgow before she moved to Saarland University, where she received her PhD in Pharmaceutical Biotechnology. Jennifer continued with post-doctoral research at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and in parallel, worked as visiting scientist at the Luxembourg Centre for Systems Biomedicine on zebrafish assays for drug screening. She currently holds a position as senior scientist at HIPS. Jennifer’s main research interests are the characterization of newly isolated anti-infective natural products and their further development, including mode-of-action and mode-of-resistance studies with novel antibiotics and their pharmacological characterization.

JoVE Journal Publications

ArticleTotal : 1
Year
Metabolic Profiling to Determine Bactericidal or Bacteriostatic Effects of New Natural Products using Isothermal Microcalorimetry
Publication title

Cited by 4

2020

Other Publications

Article
Year
Mining the cinnabaramide biosynthetic pathway to generate novel proteasome inhibitors.

Chembiochem : a European journal of chemical biology| PubMed ID: 21387511

2011
2012
2012
2013
In vivo evidence for a prodrug activation mechanism during colibactin maturation.

Chembiochem : a European journal of chemical biology| PubMed ID: 23744512

2013
2013
Discovery and biological activity of new chondramides from Chondromyces sp.

Chembiochem : a European journal of chemical biology| PubMed ID: 23959765

2013
2015
Total syntheses and biological evaluation of miuraenamides.

Angewandte Chemie (International ed. in English)| PubMed ID: 25688545

2015
Biosynthetic Studies of Telomycin Reveal New Lipopeptides with Enhanced Activity.

Journal of the American Chemical Society| PubMed ID: 26043159

2015
2015
2015
2015
2016
2016
2016
2016
2016
2016
2017
2017
Novel and revisited approaches in antituberculosis drug discovery.

Current opinion in biotechnology| PubMed ID: 28427007

2017
2017
Pyxipyrrolones: Structure Elucidation and Biosynthesis of Cytotoxic Myxobacterial Metabolites.

Angewandte Chemie (International ed. in English)| PubMed ID: 28590072

2017
2017
2018
2018
2018
2018
2018
2019
2018
-Acylated amino acid methyl esters from marine group bacteria.

Beilstein journal of organic chemistry| PubMed ID: 30591820

2018
2019
2019
2019
2019
2018
2020
Search for hits and early leads from soil bacteria to combat infectious diseases.

Journal of infection in developing countries| PubMed ID: 31804999

2018
Setting Our Sights on Infectious Diseases.

ACS infectious diseases| PubMed ID: 31808676

2020
2020
Cystobactamid 507: Concise Synthesis, Mode of Action, and Optimization toward More Potent Antibiotics.

Chemistry (Weinheim an der Bergstrasse, Germany)| PubMed ID: 31984562

2020
The glucocorticoid-induced leucine zipper mediates statin-induced muscle damage.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology| PubMed ID: 32030813

2020
2020
2020
Protein-Templated Hit Identification through an Ugi Four-Component Reaction.

Chemistry (Weinheim an der Bergstrasse, Germany)| PubMed ID: 32428268

2020
2020
2020
2020